Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
15.86
+0.25 (1.60%)
Oct 24, 2024, 4:00 PM EDT - Market closed
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $919.51 million as of October 24, 2024. Its market cap has increased by 142.30% in one year.
Market Cap
919.51M
Enterprise Value
245.25M
1-Year Change
142.30%
Ranking
Category
Stock Price
$15.86
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has increased from $829.45M to $919.51M, an increase of 10.86%. That is a compound annual growth rate of 2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2024 | 905.00M | 107.62% |
| Dec 29, 2023 | 435.90M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.10M | -18.73% |
| Jan 8, 2021 | 829.45M | - |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CARGO Therapeutics | 964.46M |
| Weave Communications | 956.55M |
| Liquidia | 945.03M |
| Zymeworks | 933.56M |
| Rapport Therapeutics | 922.46M |
| PetIQ | 918.87M |
| Capricor Therapeutics | 914.48M |
| HealthStream | 914.37M |